Gates Foundation Pledges $2.5 Billion to Transform Women's Health R&D by 2030

By: WE staff | Tuesday, 5 August 2025

• The Gates Foundation has committed a record $2.5 billion to funding women's health research and development (R&D) up to 2030
• The funding will pay for more than 40 innovations in five traditionally underfunded areas of women's health: maternal, menstrual, gynecological, and sexual health

The Gates Foundation has pledged a record $2.5 billion to drive research and development (R&D) in women's health using the money available to come through 2030. The investment is made to support over 40 innovations in five hitherto underinvested areas of women's health—maternal, menstrual, gynecological, and sexual health—with particular focus towards strengthening care delivery for women who reside in low- and middle-income countries.

The organization cited a 2021 McKinsey & Company report, which indicated that only 1 percent of global healthcare R&D is spent on female-specific conditions excluding oncology. Despite impacting half a billion women globally, preeclampsia, gestational diabetes, endometriosis, menorrhagia, and menopause are low-research priorities.

Dr. Anita Zaidi, President of the Foundation's Gender Equality Division, stressed the need for this initiative:

"Women's health has been underinvested and undervalued for far too long. We want this investment to be the start of a new chapter—an era in which women's voices, needs, and experiences lead healthcare innovation."

Anita further noted that, while this is the largest women's health R&D investment by the foundation to date, it continues to fall short of filling the enormous gaps that remain. She emphasized that women's health must be viewed as an "investable opportunity" with the potential to yield not just scientific advances but also enduring social and economic benefit.

Bill Gates, Foundation Chair, echoed the following:

"Health for women makes families stronger, economies more prosperous, and societies more equitable. It's woefully underfunded. That must change."

The foundation challenged governments, private investors, philanthropists, and global health stakeholders to co-invest and get new healthcare solutions to the women and girls most in need.

The five R&D focused areas were selected following information and first-hand experience of women residing in low-resource environments where healthcare is scarce and misdiagnosis occurs based on ignorance.

Bosede Afolabi, a prominent obstetrician-gynecologist at the University of Lagos, highlighted the cost in human lives of doing nothing:

"We see women suffer unnecessarily—and all too often die—because there is no medical innovation for conditions specific to them. Such an investment would be transformative where the need is greatest".

In addition to bettering health outcomes, the program is also poised to contribute to long-term economic gains. Studies indicate that each dollar spent on women's health returns $3 in terms of economics, and closing the gap in gender health can boost the global economy by $1 trillion each year by the year 2040.